Provisional best practices guidelines for the evaluation of bulbar dysfunction in amyotrophic lateral sclerosis.


Journal

Muscle & nerve
ISSN: 1097-4598
Titre abrégé: Muscle Nerve
Pays: United States
ID NLM: 7803146

Informations de publication

Date de publication:
05 2019
Historique:
received: 24 09 2018
revised: 24 12 2018
accepted: 02 01 2019
pubmed: 9 1 2019
medline: 23 10 2019
entrez: 9 1 2019
Statut: ppublish

Résumé

Universally established comprehensive clinical bulbar scales objectively assessing disease progression in amyotrophic lateral sclerosis (ALS) are currently lacking. The goal of this working group project is to design a best practice set of provisional bulbar ALS guidelines, available for immediate implementation within all ALS clinics. ALS specialists across multiple related disciplines participated in a series of clinical bulbar symposia, intending to identify and summarize the currently accepted best practices for the assessment and management of bulbar dysfunction in ALS Results: Summary group recommendations for individual speech, Augmentative and Alternative Communication (AAC), and swallowing sections were achieved, focusing on the optimal proposed level of care within each domain. We have identified specific clinical recommendations for each of the 3 domains of bulbar functioning, available for incorporation within all ALS clinics. Future directions will be to establish a formal set of bulbar guidelines through a methodological and evidence-based approach. Muscle Nerve 59:531-531, 2019.

Identifiants

pubmed: 30620104
doi: 10.1002/mus.26408
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

531-536

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC013547
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Gary L Pattee (GL)

Neurology Associates P.C, Lincoln, NE, U.S.A.

Emily K Plowman (EK)

Department of Speech, Language and Hearing Sciences, University of Florida, Gainesville, FL, U.S.A.

Kendrea L Focht Garand (KL)

Department of Speech Pathology and Audiology, University of South Alabama, Mobile, AL, U.S.A.

John Costello (J)

Speech and Feeding Disorders Lab, MGH Institute of Health Professions, Charlestown, MA, U.S.A., ALS Augmentative Communication Program, Boston Children's Hospital, Boston, MA, U.S.A.

Benjamin Rix Brooks (BR)

Carolinas Medical Center, Charlotte, NC, U.S.A.

James D Berry (JD)

MGH Department of Neurology, Boston, MA, U.S.A.

Richard A Smith (RA)

Center for Neurologic Study, San Diego, CA, U.S.A.

Nazem Atassi (N)

MGH Department of Neurology, Boston, MA, U.S.A.

Jennifer L Chapin (JL)

Department of Speech, Language and Hearing Sciences, University of Florida, Gainesville, FL, U.S.A.

Yana Yunusova (Y)

Department of Speech-Language Pathology, University of Toronto, Toronto, ON, CANADA.

Courtney E McIlduff (CE)

Beth Israel Deaconess Medical Center, Boston, MA, U.S.A.

Eufrosina Young (E)

State University of New York, Department of Neurology, Syracuse, NY, U.S.A.

Eric A Macklin (EA)

MGH Biostatistics Center, Boston, MA, U.S.A.

Eduardo R Locatelli (ER)

Holy Cross Hospital, Department of Neurology, Fort Lauderdale, FL, U.S.A.

Vincenzo Silani (V)

Istituto Auxologico Italiano, IRCCS, Department of Neurology and Laboratory of Neuroscience, Department of Pathophysiology and Transplantation, "Dino Ferrari" Center, Università degli studi di Milano, Milan 20122, Italy.

Daragh Heitzman (D)

Texas Neurology, P.A, Dallas, TX, U.S.A.

James Wymer (J)

University of Florida, Rehabilitation Science, Gainesville, FL, U.S.A.

Stephen A Goutman (SA)

University of Michigan, Department of Neurology, Ann Arbor, MI, U.S.A.

Deborah F Gelinas (DF)

UNC Health Care, Chapel Hill, NC, U.S.A.

Bridget Perry (B)

Speech and Feeding Disorders Lab, MGH Institute of Health Professions, Charlestown, MA, U.S.A., ALS Augmentative Communication Program, Boston Children's Hospital, Boston, MA, U.S.A.

Paige Nalipinski (P)

MGH Speech Language Pathology, Boston, MA, U.S.A.

Kaila Stipancic (K)

Speech and Feeding Disorders Lab, MGH Institute of Health Professions, Charlestown, MA, U.S.A., ALS Augmentative Communication Program, Boston Children's Hospital, Boston, MA, U.S.A.

Meghan O'Brien (M)

Speech and Feeding Disorders Lab, MGH Institute of Health Professions, Charlestown, MA, U.S.A., ALS Augmentative Communication Program, Boston Children's Hospital, Boston, MA, U.S.A.

Stacey L Sullivan (SL)

MGH Speech Language Pathology, Boston, MA, U.S.A.

Erik P Pioro (EP)

Cleveland Clinic, Department of Neurology, Cleveland, OH, U.S.A.

Gisella Gargiulo (G)

National Scientific and Technical Research Council, Buenos Aires, Argentina.

Jordan R Green (JR)

Speech and Feeding Disorders Lab, MGH Institute of Health Professions, Charlestown, MA, U.S.A., ALS Augmentative Communication Program, Boston Children's Hospital, Boston, MA, U.S.A.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH